Indivior Pharmaceuticals (INDV) FCF Margin (2024 - 2026)
Indivior Pharmaceuticals' (INDV) quarterly FCF Margin came in at 9.15% in Q1 2026, down 3546.0% year-on-year from 0.27% in Q1 2025, and up 86.63% quarter-over-quarter from 68.44% in Q4 2025.
Indivior Pharmaceuticals (INDV) FCF Margin (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' FCF Margin history runs 3 years deep, the most recent figure standing at 9.15% for Q1 2026.
- On a quarterly basis, FCF Margin fell 3546.0% year-over-year to 9.15% in Q1 2026; TTM through Mar 2026 was 14.87%, a 2478.0% decrease from a year earlier, with the FY2025 full-year figure at 7.51%, down 810.0% from the prior year.
- FCF Margin rose to 9.15% in Q1 2026 per INDV's latest filing, from 68.44% in the prior quarter.
- Across five years, FCF Margin topped out at 46.69% in Q2 2025 and bottomed at 68.44% in Q4 2025.
- The 3-year median for FCF Margin is 9.15% (2026), against an average of 2.41%.
- Biggest YoY gain for FCF Margin was 4005 bps in 2025; the steepest drop was 5740 bps in 2025.
- Year by year, FCF Margin stood at 11.04% in 2024, then tumbled by 520 bps to 68.44% in 2025, then soared by 87 bps to 9.15% in 2026.
- Per Business Quant, the three latest INDV FCF Margin figures stand at 9.15% (Q1 2026), 68.44% (Q4 2025), and 18.79% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Indivior Pharmaceuticals | 1.00 Bn | 829.65 Mn | 277.00 Mn | -9.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.15% |
| Dec 31, 2025 | -68.44% |
| Sep 30, 2025 | -18.79% |
| Jun 30, 2025 | 46.69% |
| Mar 31, 2025 | 26.32% |
| Dec 31, 2024 | -11.04% |
| Sep 30, 2024 | -1.63% |
| Jun 30, 2024 | 28.09% |
| Mar 31, 2024 | -13.73% |